Home > NRC Library > ADAMS Public Documents

Amend 1 to License 29-19396-01 for Exxon Biomedical Science, Exxon Corp,amending license in entirety.

Accession Number: ML20128H775

Date Released: Sunday, October 27, 2024

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML20128H787 - Forwards Amend 1,renewing License 29-19396-01. (2 page(s), 6/12/1985)
• ML20128H798 - Ack receipt of application for renewal of License 29-19396-01. (3 page(s), 5/20/1985)
• ML20128H801 - Forwards application for renewal/amend to License 29-19396-01 to include activities under License 29-14800-01. (2 page(s), 4/4/1985)
• ML20128H813 - Application for renewal/amend to License 29-19396-01 to include activities under License 29-14800-01.Related info encl.Fee paid. (43 page(s), 4/4/1985)
• ML20128H826 - Requests payment of addl fee for 850404 application for renewal of License 29-19396-01. (1 page(s), 4/25/1985)
• ML20128H838 - Forwards payment of addl fee for application for License 29-19396-01. (1 page(s), 5/6/1985)
• ML20128H866 - Forwards revised application for amend to License 29-19396-01,incorporating suggested NRC mods.Unlabelled containers of C-14 or H-3 leaving Room A300 will not exceed 0.1 mCi or 1 mCi,respectively. (1 page(s), 4/24/1985)
• ML20128H881 - Application for amend to License 29-19396-01,incorporating suggested NRC mods re use of C-14 & H-3 for research. Related info encl. (49 page(s), 4/4/1985)